Orchard Therapeutics

NASDAQ: ORTX · Real-Time Price · USD
16.70
0.05 (0.30%)
At close: Jan 23, 2024, 10:00 PM

Orchard Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
68.42M 55.91M
Short-Term Investments
75.33M 164.19M
Long-Term Investments
n/a -4.09M
Other Long-Term Assets
8.92M 13.86M
Receivables
14.41M 32.2M
Inventory
3.4M 2.02M
Other Current Assets
9.99M 23.01M
Total Current Assets
168.15M 275.32M
Property-Plant & Equipment
30.91M 29.08M
Goodwill & Intangibles
3.56M 4.15M
Total Long-Term Assets
50.76M 47.09M
Total Assets
218.91M 322.41M
Account Payables
9.32M 10.01M
Deferred Revenue
959K 346K
Short-Term Debt
15.85M 8.12M
Other Current Liabilities
34.44M 24.32M
Total Current Liabilities
60.57M 42.79M
Long-Term Debt
42.24M 51.36M
Other Long-Term Liabilities
7.52M 5.78M
Total Long-Term Liabilities
60.08M 69.67M
Total Liabilities
120.64M 112.46M
Total Debt
58.09M 59.48M
Common Stock
16.42M 16.25M
Retained Earnings
-900.88M -750.22M
Comprehensive Income
26.02M 3.25M
Shareholders Equity
98.26M 209.95M
Total Investments
75.33M 164.19M